Talman Pizzey - Jul 30, 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Fiona Sutherland, Attorney-in-Fact
Stock symbol
TIC
Transactions as of
Jul 30, 2025
Transactions value $
$0
Form type
4
Date filed
8/1/2025, 06:05 PM
Previous filing
Apr 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PIZZEY TALMAN CHIEF EXECUTIVE OFFICER, Director C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL /s/ Fiona Sutherland, Attorney-in-Fact 2025-08-01 0002042765

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TIC Common Stock Options Exercise $0 +36.7K +9.17% $0.00 437K Jul 30, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIC Restricted Stock Units Options Exercise $0 +36.7K +100% $0.00 73.3K Jul 30, 2025 Common Stock 36.7K Direct F2, F3
holding TIC Performance Based Restricted Stock Units 110K Jul 30, 2025 Common Stock 110K Direct F4, F5
holding TIC Restricted Stock Units 73.3K Jul 30, 2025 Common Stock 73.3K Direct F2, F6
holding TIC Performance Based Restricted Stock Units 147K Jul 30, 2025 Common Stock 147K Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F3 These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
F4 Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F5 Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
F6 These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
F7 These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.